Show simple item record

dc.contributor.authorRowen, Robert Jay
dc.contributor.authorRobins, Howard
dc.date.accessioned2020-04-21T03:21:42Z
dc.date.available2020-04-21T03:21:42Z
dc.date.issued2020-03
dc.identifier.urihttps://globalent.co.za/wp-content/uploads/2020/03/Corona-Published-1.pdfen_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/1127
dc.description.abstractMany viruses require reduced sulfhydryl groups for cell fusion and entry. Corona viruses, including SARS-CoV-2 (the cause of the condition now named coronavirus disease 2019 or COVID-19), are rich in cysteine, which residues must be intact for viral activity. Sulfhydryl groups are vulnerable to oxidation. Ozone therapy, a very inexpensive and safe modality may safely exploit this critical vulnerability in many viruses, inclusive of SARS-CoV-2.en_US
dc.languageEnglishen_US
dc.subjectCoronavirusen_US
dc.subjectCOVID-19en_US
dc.subjectOzoneen_US
dc.subjectAntiviral Agentsen_US
dc.subjectTherapeuticsen_US
dc.titleA Plausible Penny Costing Effective Treatment for Corona Virus - Ozone Therapyen_US
eihealth.countryUnited Statesen_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalJournal of Infectious Diseases and Epidemiologyen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record